Delivery Order SPE2DB22D2007-SPE2DB23FJ4HM
Award Date 7/20/23
Potential Completion Date 7/21/23
Potential Value $61
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $172,300 delivery order to Amerisourcebergen Drug Corporation for pharmaceutical item 4561868289, described as IPRAT-ALBUT 0.5-3(2.5) MG/3 ML UD 3ML. Performance will take place in Conshohocken, Pennsylvania under a firm fixed price contract spanning from August 18 to August 21, 2023. As a major provider of medical supplies and equipment to the Department of Defense, this order supports the DLA's mission to provide critical pharmaceuticals and medical...
- The Defense Logistics Agency awarded a $60,720 delivery order to Amerisourcebergen Drug Corporation for pharmaceutical item 4561838081. The order is for IPRAT-ALBUT 0.5-3(2.5) MG/3 ML UD 3ML to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania under a firm fixed price contract. As a major provider of medical supplies and logistics support to the Department of Defense, this order supports the Defense Logistics Agency's mission to provide critical pharmaceuticals and...
- The Defense Logistics Agency awarded a $60,720 delivery order to Amerisourcebergen Drug Corporation for pharmaceutical item 4561404311. The order is for 3 milliliter units of IPRAT-ALBUT 0.5-3(2.5) MG/3 ML UD 3ML to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania. The firm fixed price order is valued at sixty thousand, seven hundred twenty dollars and has a period of performance from July 4, 2023 through July 5, 2023 to support the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a $22,820 delivery order to Amerisourcebergen Drug Corporation for pharmaceutical item 4561791760. The order is for IPRAT-ALBUT 0.5-3(2.5) MG/3 ML UD 3ML to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania under a firm fixed price contract. The delivery order was issued on August 12, 2023 and work is scheduled for completion by August 14, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support of the...
- The Defense Logistics Agency awarded a $242,880 delivery order to Amerisourcebergen Drug Corporation for pharmaceutical item 4561542173. The order is for IPRAT-ALBUT 0.5-3(2.5) MG/3 ML UD 3ML to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania under a firm fixed price contract. As a major provider of medical supplies and pharmaceuticals to the Department of Defense, this order supports the Defense Logistics Agency's mission to provide crucial healthcare products and...
- The Defense Logistics Agency awarded a $22,820 delivery order to Amerisourcebergen Drug Corporation for pharmaceutical item 4561802770. The order is for IPRAT-ALBUT 0.5-3(2.5) MG/3 ML UD 3ML bottles to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania under a firm fixed price contract structure. The delivery order was issued on August 14, 2023 and work is scheduled for completion by August 15, 2023. No set-aside designations or subcontracting arrangements were...
- The Defense Logistics Agency awarded a $62,080 delivery order to Amerisourcebergen Drug Corporation for pharmaceutical item 4561491819. The order is for IPRAT-ALBUT 0.5-3(2.5) MG/3 ML UD 3ML to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania under a firm fixed price arrangement. As a major provider of medical supplies and pharmaceuticals to the Department of Defense, this order supports the Defense Logistics Agency's mission to provide critical healthcare products...
- The Defense Logistics Agency awarded a delivery order valued at $22,820 to Amerisourcebergen Drug Corporation for the product "4561652061 ! IPRAT-ALBUT 0.5-3(2.5) MG/3 ML UD 3ML." The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 31, 2023 through August 1, 2023 under a firm fixed price contract. As the Defense Logistics Agency supports procurement for the Department of Defense, this delivery order is...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $84,060 to Amerisourcebergen Drug Corporation for the product "4561801128 ! IPRAT-ALBUT 0.5-3(2.5) MG/3 ML UD 3ML." The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 14-15, 2023. As the DLA supports the procurement of medical supplies and pharmaceuticals for the U.S. military and other government agencies, this order...
- The Defense Logistics Agency awarded a $60,720 delivery order to Amerisourcebergen Drug Corporation for pharmaceutical product 4561890567. The order is for IPRAT-ALBUT 0.5-3(2.5) MG/3 ML UD 3ML to be delivered to a location in Conshohocken, Pennsylvania by August 22, 2023. Amerisourcebergen will provide the product under a firm fixed price contract. No additional details were provided regarding the original solicitation, any overarching contract vehicles, or subcontracting arrangements. The...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB23FJ4HMDelivery Order
The Defense Logistics Agency awarded a $60,720 delivery order to Amerisourcebergen Drug Corporation for pharmaceutical item 4561557384, described as IPRAT-ALBUT 0.5-3(2.5) MG/3 ML UD 3ML. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania, with performance required from July 20-21, 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, this order was placed under an existing DLA pharmaceuticals contract vehicle to fulfill short-term clinical needs at a military treatment facility in the Mid-Atlantic region. No subcontractors or set-aside designations were identified.
Generated 12/20/23, 3:23 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $61 | 7/20/23 |